Austin’s Luminex Corporation, a company committed to the global advancement of healthcare and research, announced that next Sunday they will unveil ARIES™, a system for infectious diseases testing.
The system will be unveiled during the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), set to take place in Barcelona, Spain, from May 10-13, 2014. Luminex said that the system boasts a “scalable throughput, easy to use design, and networked data management software will deliver rapid results with a simple workflow.” BioNews Texas columnist Susan Ardizzoni recently profiled how, as part of ARIES’ new unveiling and eventual launch later this year, Luminex has included a norovirus assay with the new diagnostic solution.
According to the company, the system’s launch menu will feature 5 assays: the Flu A/B and RSV, HSV 1&2, Norovirus and Clostridium difficile (C. diff). The system will be including more items in the near future. These assays will be revealed on a separate date.
Russell W. Bradley, Luminex’s senior vice president of corporate development and global marketing, said that ARIES will transform molecular diagnostic testing because of its ability to fuse with laboratories effortlessly.
The Luminex system will allow laboratories to process samples and produce results more efficiently and effectively, improve quality control policies and compliance, and extend its services to healthcare institutions and physicians in order to boost care given to patients.
ARIES’ first unveiling will be on May 11, 2014, at 11:00 AM CEST, at booth No. 23. Mr. Bradley himself will be there to introduce the new system, do a demonstration, and to answer questions.